Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We investigated whether injecting drug use was a risk factor for methicillin resistance among inpatients with Staphylococcus aureus bloodstream infections (SABSIs) at an Australian health service. In 273 inpatients, 46 (16.9%) of SABSIs were methicillin-resistant S. aureus (MRSA). MRSA was more frequent in those who had injected drugs in the past 6 months (20.6%) compared with other inpatients (15.7%). Injecting drug use was associated with a 4.82-fold (95% confidence interval = 1.54-16.29) increased odds of MRSA after accounting for confounders.

Original publication

DOI

10.1111/imj.16529

Type

Journal

Internal medicine journal

Publication Date

11/2024

Volume

54

Pages

1903 - 1908

Addresses

Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.

Keywords

Humans, Bacteremia, Staphylococcal Infections, Substance Abuse, Intravenous, Risk Factors, Methicillin Resistance, Adult, Aged, Middle Aged, Australia, Female, Male, Methicillin-Resistant Staphylococcus aureus